INTERNATIONAL FLAVORS & FRAGRANCES INC
IFFAPI behind this page
IFF Q4 2025 request
Playground key active
/api/financials?ticker=IFF&year=2025&quarter=4
Pick an endpoint and run the request.Income Statement
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Revenue | 2,589 | 2,771 | -6.6% |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 802 | 819 | -2.1% |
| Pharma Solutions · Operating Segments | 0 | 248 | -100.0% |
| Scent · Operating Segments | 610 | 578 | +5.5% |
| Taste · Operating Segments | 588 | 576 | +2.1% |
Show Geography breakouts |
|||
| Asia | 612 | 674 | -9.2% |
| EMEA | 889 | 927 | -4.1% |
| Latin America | 343 | 358 | -4.2% |
| North America | 745 | 812 | -8.3% |
Show — breakouts |
|||
| Revenue | 589 | 550 | +7.1% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2,589 | 2,771 | -6.6% |
| Cost of Revenue | 1,699 | 1,791 | -5.1% |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 638 | 630 | +1.3% |
| Pharma Solutions · Operating Segments | 0 | 173 | -100.0% |
| Scent · Operating Segments | 370 | 330 | +12.1% |
| Taste · Operating Segments | 367 | 360 | +1.9% |
Show — breakouts |
|||
| Cost of Revenue | 322 | 298 | +8.1% |
| Gross Profit | 890 | 980 | -9.2% |
| Research & Development | 174 | 170 | +2.4% |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 15 | 13 | +15.4% |
| Pharma Solutions · Operating Segments | 0 | 6 | -100.0% |
| Scent · Operating Segments | 61 | 58 | +5.2% |
| Taste · Operating Segments | 44 | 43 | +2.3% |
Show — breakouts |
|||
| Research & Development | 55 | 50 | +10.0% |
| Selling, General & Administrative | 469 | 517 | -9.3% |
Show Business Segments breakouts |
|||
| Food Ingredients · Operating Segments | 100 | 108 | -7.4% |
| Pharma Solutions · Operating Segments | 0 | 31 | -100.0% |
| Scent · Operating Segments | 91 | 101 | -9.9% |
| Taste · Operating Segments | 101 | 104 | -2.9% |
Show — breakouts |
|||
| Selling, General & Administrative | 89 | 95 | -6.3% |
| Operating Income | 97 | 127 | -23.6% |
| Interest Income | 4 | 6 | -33.3% |
| Other Non-Operating Income (Expense) | 21 | 138 | -84.8% |
| Income Before Taxes | 22 | -115 | +119.1% |
| Income Tax Expense (Benefit) | -9 | -55 | +83.6% |
| Net Income | 31 | -60 | +151.7% |
| Comprehensive Income | 64 | -827 | +107.7% |
| EPS (Basic) | 0.12 | -0.23 | +152.2% |
| EPS (Diluted) | 0.12 | -0.23 | +152.2% |
| Wtd Avg Shares (Basic) | 0 | 1 | -100.0% |
| Wtd Avg Shares (Diluted) | 0 | 0 | — |
| Net Income Loss Attributable To Noncontrolling Interest | 0 | 0 | — |
| Foreign Currency Transaction Gain Loss Before Tax | -30 | -19 | -57.9% |
Balance Sheet
| Metric | Q4 2025 | Q4 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 590 | 469 | +25.8% |
| Inventory | 2,245 | 2,133 | +5.3% |
| Total Current Assets | 5,594 | 7,968 | -29.8% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 4,029 | 3,739 | +7.8% |
Show Geography breakouts |
|||
| Non Us | 2,409 | 2,129 | +13.2% |
| US | 1,620 | 1,610 | +0.6% |
| Operating Lease Right-of-Use Assets | 579 | 589 | -1.7% |
Show Disposal Group Classification breakouts |
|||
| Disposal Group Heldforsale Not Discontinued Operations · SCL Disposal Group | 7 | — | — |
| Goodwill | 8,269 | 9,075 | -8.9% |
Show Business Segments breakouts |
|||
| Health & Biosciences | 4,465 | 4,295 | +4.0% |
| Scent | 1,508 | 1,465 | +2.9% |
| Taste | 2,296 | — | — |
| Intangible Assets | 6,043 | 6,445 | -6.2% |
| Other Non-Current Assets | 1,025 | 907 | +13.0% |
| Total Assets | 25,539 | 28,723 | -11.1% |
| Current Liabilities | |||
| Accounts Payable | 1,287 | 1,283 | +0.3% |
| Commercial Paper | 314 | — | — |
| Current Portion of Long-Term Debt | -1,254 | -1,413 | +11.3% |
| Total Current Liabilities | 3,933 | 4,352 | -9.6% |
| Debt Current | 1,254 | 1,413 | -11.3% |
| Non-Current Liabilities | |||
| Long-Term Debt | 4,740 | 7,564 | -37.3% |
| Long-Term Debt | 5,637 | — | — |
| Operating Lease Liabilities | 533 | 550 | -3.1% |
| Deferred Tax Liabilities | 1,379 | 1,594 | -13.5% |
| Other Non-Current Liabilities | 582 | 627 | -7.2% |
| Stockholders' Equity | |||
| Common Stock | 35 | 35 | 0.0% |
| Retained Earnings | -3,417 | -2,647 | -29.1% |
| Accumulated Other Comprehensive Income | -1,430 | -2,527 | +43.4% |
| Total Stockholders' Equity | 14,154 | 13,834 | +2.3% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -153 | -99 | -54.5% |
| Accumulated Gain Loss Net Cash Flow Hedge Parent | -4 | -2 | -100.0% |
| Accumulated Other Comprehensive Income | -1,430 | -2,527 | +43.4% |
| Accumulated Translation Adjustment | -1,273 | -2,426 | +47.5% |
| Total Liabilities & Equity | 25,539 | 28,723 | -11.1% |
Cash Flow Statement
| Metric | YTD Q4 2025 | YTD Q4 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 237 | 243 | -2.5% |
| Stock-Based Compensation | 16 | 18 | -11.1% |
| Deferred Income Taxes | -57 | -180 | +68.3% |
| Change in Accounts Receivable | 127 | 59 | +115.3% |
| Change in Inventory | 88 | -31 | +383.9% |
| Change in Accounts Payable | -85 | 74 | -214.9% |
| Net Cash from Operations | 318 | 389 | -18.3% |
| Investing Activities | |||
| Capital Expenditures | -188 | -160 | -17.5% |
| Net Cash from Investing | -157 | -281 | +44.1% |
| Financing Activities | |||
| Tax Withholding for Share Compensation | -1 | -1 | 0.0% |
| Net Cash from Financing | -200 | -162 | -23.5% |
| Supplemental | |||
| Interest Paid | 54 | 92 | -41.3% |
| Unpaid Capital Expenditures | 84 | 84 | 0.0% |
| Other Cash Flow | |||
| Net Change in Cash | -31 | -98 | +68.4% |
Values in millions USD. Source: SEC EDGAR 10-K filing.